Design strategies were devised for alpha/beta-peptide foldameric analogues of the
antiangiogenic anginex with the goal of mimicking the diverse structural features
from the unordered conformation to a folded beta-sheet in response to membrane interactions.
Structure-activity relationships were investigated in the light of different beta-sheet
folding levels.
